• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

Introduction to Tert-Butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate (CAS No. 1434141-81-7)

Tert-Butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate, identified by its Chemical Abstracts Service number CAS No. 1434141-81-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the pyrrolidine class, a heterocyclic structure that is widely recognized for its versatility in drug design and development. The presence of both fluoro and hydroxyl substituents in its molecular framework imparts unique chemical properties, making it a promising candidate for various biochemical applications.

The structural features of Tert-butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate contribute to its potential utility in the synthesis of bioactive molecules. The tert-butyl group enhances lipophilicity, facilitating better membrane penetration, while the difluoro substitution at the 3-position introduces electron-withdrawing effects that can modulate reactivity and binding affinity. The hydroxypyrrolidine core is particularly noteworthy, as it mimics natural bioactive scaffolds found in numerous pharmacologically relevant compounds.

In recent years, there has been a surge in research focused on fluorinated heterocycles due to their ability to improve metabolic stability, binding affinity, and pharmacokinetic profiles of drug candidates. Studies have demonstrated that fluorine atoms can significantly alter the electronic properties of molecules, leading to enhanced interactions with biological targets. The incorporation of fluorine into the pyrrolidine ring of Tert-butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate aligns with this trend, positioning it as a valuable building block for medicinal chemists.

One of the most compelling aspects of this compound is its potential role in the development of novel therapeutic agents. The hydroxypyrrolidine moiety is a common motif in bioactive molecules, particularly those targeting enzyme inhibition and receptor binding. For instance, derivatives of pyrrolidine have been explored in the treatment of neurological disorders, cardiovascular diseases, and infectious diseases. The unique combination of substituents in Tert-butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate suggests that it could serve as a scaffold for designing molecules with improved efficacy and selectivity.

The pharmaceutical industry has increasingly recognized the importance of fluorinated compounds in drug development. Fluorine atoms can enhance drug-like properties such as lipophilicity, solubility, and resistance to metabolic degradation. Moreover, fluorine labeling techniques are widely used in diagnostic imaging and probes for biochemical assays. Given these advantages, Tert-butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate could be employed in the synthesis of fluorinated probes or intermediates for research applications.

Recent advancements in computational chemistry have further enhanced the utility of compounds like Tert-butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate. Molecular modeling studies have shown that modifications to this scaffold can fine-tune binding interactions with biological targets. For example, virtual screening techniques have been used to identify potential lead compounds based on their predicted binding affinities to enzymes or receptors. The structural flexibility offered by the pyrrolidine ring, combined with the electronic effects of fluorine and hydroxyl groups, makes this compound an attractive candidate for such computational studies.

The synthesis of Tert-butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate presents an interesting challenge due to its complex structural features. However, modern synthetic methodologies have made significant strides in facilitating the preparation of such molecules. Techniques such as fluorochemical reactions and transition-metal-catalyzed couplings have enabled efficient access to fluorinated heterocycles. These advances not only streamline the synthesis but also open up new possibilities for functionalizing the molecule further.

In conclusion,Tert-butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate (CAS No. 1434141-81-7) represents a promising compound with diverse applications in pharmaceutical chemistry and medicinal biology. Its unique structural features make it a valuable tool for drug discovery and development. As research continues to uncover new methodologies for fluorinated heterocycles,Tert-butyl 3,3-difluoro-4-hydroxypyrrolidine-1-carboxylate is likely to play an increasingly important role in shaping future therapeutic strategies.

• 1174020-50-8(Tert-butyl (3R,4R)-3-fluoro-4-hydroxypyrrolidine-1-carboxylate)
• 1186688-52-7(tert-butyl 4,4-difluoro-3-hydroxypiperidine-1-carboxylate)
• 195447-25-7(tert-Butyl 3,3-difluoropyrrolidine-1-carboxylate)
• 1174020-51-9(tert-butyl (3S,4S)-3-fluoro-4-hydroxypyrrolidine-1-carboxylate)
• 1209780-71-1(tert-butyl 3,3-difluoro-4-hydroxy-piperidine-1-carboxylate)
• 1174020-49-5(tert-butyl (3R,4S)-3-fluoro-4-hydroxypyrrolidine-1-carboxylate)
• 1379325-25-3(Tert-butyl 3-fluoro-4-hydroxypyrrolidine-1-carboxylate)
• 2055223-76-0(tert-butyl cis-3-fluoro-4-hydroxypyrrolidine-1-carboxylate)
• 869481-93-6(tert-butyl trans-3-fluoro-4-hydroxypyrrolidine-1-carboxylate)
• 1174020-48-4(tert-butyl (3S,4R)-3-fluoro-4-hydroxypyrrolidine-1-carboxylate)